Business Objectives Experimentation ROI 
CIO Business Intelligence
JANUARY 14, 2025
How does our AI strategy support our business objectives, and how do we measure its value? The time for experimentation and seeing what it can do was in 2023 and early 2024. So the organization as a whole has to have a clear way of measuring ROI, creating KPIs and OKRs or whatever framework theyre using.
CIO Business Intelligence
OCTOBER 24, 2024
As they look to operationalize lessons learned through experimentation, they will deliver short-term wins and successfully play the gen AI — and other emerging tech — long game,” Leaver said. Their top predictions include: Most enterprises fixated on AI ROI will scale back their efforts prematurely.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO Business Intelligence
JANUARY 7, 2025
The US President-elect promises many changes impacting enterprises , including import tariffs, immigration deportations, energy policy changes, and relaxation of other business regulations that will impact supply chains, labor pools, and other global consequences.
CIO Business Intelligence
JULY 5, 2024
This is why many enterprises are seeing a lot of energy and excitement around use cases, yet are still struggling to realize ROI. So, to maximize the ROI of gen AI efforts and investments, it’s important to move from ad-hoc experimentation to a more purposeful strategy and systematic approach to implementation.
CIO Business Intelligence
JULY 24, 2024
Key strategies for exploration: Experimentation: Conduct small-scale experiments. Data-driven decisions: Leverage data and analytics to assess new technologies’ potential impact and ROI. It shows the importance of eliminating investments that no longer align with core business objectives.
CIO Business Intelligence
JANUARY 2, 2024
He plans to scale his company’s experimental generative AI initiatives “and evolve into an AI-native enterprise” in 2024. This vision represents a fundamental shift, positioning AI as an integral part of our business fabric rather than just an add-on. That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies.
CIO Business Intelligence
JUNE 28, 2023
As Belcorp considered the difficulties it faced, the R&D division noted it could significantly expedite time-to-market and increase productivity in its product development process if it could shorten the timeframes of the experimental and testing phases in the R&D labs.
Expert insights. Personalized for you.
141 
Let's personalize your content